48 results
Page 2 of 3
S-3
ap1so 50cmnno43
15 Aug 22
Shelf registration
6:20pm
S-3
EX-1.1
wdh5bdulv8z
15 Aug 22
Shelf registration
6:20pm
8-K
EX-99.1
xgy88fr
15 Aug 22
Unicycive Announces Second Quarter Financial Results and Provides Business Update
6:18pm
8-K
EX-99.1
d1gofm8
18 Jul 22
Expands and accelerates Renazorb opportunity in important markets for patients with hyperphosphatemia through local partner with deep domain expertise
4:15pm
8-K
EX-99.1
aql45
31 Mar 22
Unicycive Announces Full Year 2021 Financial Results and Provides Business Update
11:08am
10-K
6dwkn0 7y7yaelc3jvj
31 Mar 22
Annual report
6:18am
8-K
EX-99.1
4ump2n0n
29 Nov 21
Unicycive Therapeutics Receives Confirmatory Guidance on Renazorb Regulatory Pathway
9:45am
8-K
EX-99.1
7yxk3yysa
12 Nov 21
Unicycive Therapeutics Announces Third Quarter 2021 Financial Results
6:36am
8-K
EX-99.1
umap8al3 cibnao
16 Aug 21
Unicycive Therapeutics Announces Second Quarter 2021 Financial Results
9:22am
10-Q
801limy
16 Aug 21
Quarterly report
6:06am
424B4
q1xsa9r
14 Jul 21
Prospectus supplement with pricing info
1:59pm
S-1/A
76dm rqak4yzrjhcdjwn
7 Jun 21
IPO registration (amended)
7:01am